CCM
MDCO

Catapult Capital Management’s Medicines Co MDCO Stock Holding History

Catapult Capital Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-50,000
Closed -$1.93M – 280
2013
Q4 		$1.93M Buy
+50,000
New +$1.79M 0.46% 64

Other funds holding MDCO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Catapult Capital Management's MDCO Position: Q1 2014 in Review

Catapult Capital Management sold out of Medicines Co (MDCO) in Q1 2014, closing a stake of 50,000 shares — an estimated $1.93M sold.

Catapult Capital Management first reported a position in MDCO in Q4 2013 and held it in 1 quarter. The position peaked at $1.93M in Q4 2013. 166 funds tracked by Wall St. Rank hold MDCO as of Q1 2014.

  • Catapult Capital Management reported no remaining Medicines Co position as of Q1 2014 after selling out during the quarter.
  • Catapult Capital Management sold 50,000 Medicines Co shares in Q1 2014, an estimated $1.93M.
  • Catapult Capital Management first reported a position in Medicines Co in Q4 2013 and held it in 1 quarter.
  • Catapult Capital Management's Medicines Co position peaked at $1.93M in Q4 2013.
  • 166 funds tracked by Wall St. Rank held Medicines Co as of Q1 2014.

Based on Catapult Capital Management's 13F filing for Q1 2014, filed 15 May 2014.